2BBBullish & Bearish
XBiotech Inc. (XBIT) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 37 out of 100.
XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases.
XBiotech Inc.’s current 2BB score is 37 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 26 | Low |
| Momentum | 49 | Stable |
| Financial strength | 27 | Weak |
| Quality | 80 | Very Strong |
| Risk | 44 | Moderate |
| Headquarters | Austin, Texas, United States |
| Founded | 2005 |
| Employees | 87 |
| 52-week range | $2.09 – $3.61 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-10 | — | — | — | — |
| 2026-08-11 | — | — | — | — |
| 2026-05-12 | — | — | — | — |
| 2026-03-16 | — | — | — | — |